Can Hydroxychloroquine Help Fight COVID-19? How Risky Is It?

The ‘proof’ that the drug works to treat COVID-19 has been called ‘inadequate’ by experts. 

1 min read

Can anti-malarial drug Hydroxychloroquine be used to treat COVID-19? Is there adequate evidence to say this?

India, which is the world’s largest manufacturer the drug, supplying 70 percent of the world’s needs, had on 25 March placed a limited ban on its export along with other drugs to fight COVID-19.

On 4 April, the limited ban was extended to a complete ban, leading to Trump resorting to arm-twisting the country into meeting the order placed by the US in March.

Hours after this, India lifted the ban partially, and even ramped up production of the drug, saying it would provide it to countries in required quantities on humanitarian grounds, after meeting its domestic needs.

Guests: Dr Dhruv Kazi, Associate Director, Richard A and Susan F Smith Center for Outcomes Research and Director, Cardiac Critical Care Unit, Beth Israel Deaconess Medical Center, Harvard Medical School

Dr Suraja Harilal, General Surgeon, ESI Hospital, Thrissur

Daara Patel, Secretary, IDMA

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Speaking truth to power requires allies like you.
Become a Quint Insider

or more


3 months
12 months
12 months
Check Insider Benefits
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!